About Semaglutide
            
            Class: | GLP-1 receptor agonist  
Use: | Indicated for the treatment of type 2 diabetes mellitus to improve glycemic control in adults, as an adjunct to diet and exercise.  
Adult dose: | Initial dose of 3 mg once daily for 30 days, then may increase to 7 mg once daily; if additional glycemic control is needed, may increase to 14 mg once daily.  
Pediatric dose: | Safety and efficacy have not been established in pediatric patients under 18 years of age.  
Side effects: | Common side effects incl
         
        
            
                
                
                    
                        Drug Class
                    
                    GLP-1 receptor agonist
                 
                
                
                    
                        Uses & Indications
                    
                    Indicated for the treatment of type 2 diabetes mellitus to improve glycemic control in adults, as an adjunct to diet and exercise.
                 
                
                
                    
                        Storage Requirements
                    
                    Store at 20°C to 25°C (68°F to 77°F); protect from light and moisture. Once opened, can be stored in the original container for up to 30 days.
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: Novo Nordisk A/S, DENMARK
                    
                    
                    Package Size
                    30’s (10’s Blister x 3)
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 641.00
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        Initial dose of 3 mg once daily for 30 days, then may increase to 7 mg once daily; if additional glycemic control is needed, may increase to 14 mg once daily.
                    
                    
                        Pediatric Dose
                    
                    
                        Safety and efficacy have not been established in pediatric patients under 18 years of age.
                    
                 
                
                
                    
                        Side Effects
                    
                    Common side effects include nausea, vomiting, diarrhea, abdominal pain, and constipation.
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), and in patients with a history of serious hypersensitivity reactions to semaglutide or any of its components.
         
        
        
            
                Important Warnings
            
            Risk of thyroid C-cell tumors; pancreatitis; renal impairment; hypoglycemia when used with insulin or sulfonylureas; and not recommended for use in patients with severe gastrointestinal disease.
         
        
        
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.